A combination of oligonucleotide hybridization-based DNA sequencing using the Affymetrix GeneChip® platform and dideoxy-based DNA sequencing of the coding regions and splice sites of all genes.
Examines 11 genes known to cause hypertrophic cardiomyopathy (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, ACTC, MYL2, MYL3, LAMP2, PRKAG2, GLA).
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
2 - 5 weeks
Test sent to Harvard Medical School Partners HealthCare Center for Personalized Genetic Medicine (PCPGM).